Fundraising Fox

Thumbnail for Escient Pharmaceuticals

San Diego, US · Founded 2017 · 10 known investors

Biotech

Founders & leadership

Thumbnail for Escient Pharmaceuticals was founded in 2017 by Alain Baron.

AB
Alain BaronFounder
JK
JeenJoo KangNamed on SEC filing
RT
Robert TjianNamed on SEC filing
MB
Marcus BoehmNamed on SEC filing

Board

ASAndrew Schwab
Andrew Schwabin𝕏Board directorManaging Partner at 5AM Ventures

Investors · 10

5AM VenturesBoston · $100K – $4M
Avego BioScience CapitalAlpharetta
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Sanofi VenturesCambridge · $5M
The Column GroupSan Francisco · $30M
AbingworthreportedLondon · $15M – $30M
ALTITUDE LIFE SCIENCE VENTURESreportedKirkland
Cowen Healthcare InvestmentsreportedNew York
Osage University PartnersreportedBala Cynwyd

Reported raises · per SEC filings

Form D private placements

$108.8M disclosed across 3 rounds · 2018–2022

▶$60MraisedNov 2022 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter HirthDirector
  • Charles ZukerDirector
  • Kathleen Sereda GlaubDirector
  • Jason HaflerDirector
  • Kevin RaidyDirector
  • Aaron MishelExecutive Officer
  • Joshua GrassExecutive Officer, Director
  • JeenJoo KangDirector
  • Andrew SchwabDirector
  • Marcus BoehmExecutive Officer
Offering amount
$120M
Amount sold
$60M
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.8MraisedSep 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marcus BoehmExecutive Officer
  • Charles ZukerDirector
  • Kevin RaidyDirector
  • Kathleen GlaubDirector
  • Alain BaronExecutive Officer, Director
  • Andrew SchwabDirector
  • JeenJoo KangDirector
  • Jason HaflerDirector
  • Peter HirthDirector
Offering amount
$77.5M
Amount sold
$38.8M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedApr 2018 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JeenJoo KangDirector
  • Robert TjianDirector
  • Alain BaronExecutive Officer, Director
  • Marcus BoehmExecutive Officer
  • Andrew SchwabDirector
Offering amount
$40M
Amount sold
$10M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Cure’s Biotech Funding Tracker 2026wewillcure.com · May 2026Escient Pharmaceuticals Announces $120 Million Series C Financing - Escient pharmaceuticalsescientpharma.com · Nov 2022Escient Pharmaceuticals Raises $77.5 Million Series B Round and Initiates a Phase 1/1b Clinical Trial of EP547, a MRGPR-targeted Therapy to Treat Cholestatic and Uremic Pruritusbusinesswire.com · Sep 2020Leadership - Escient pharmaceuticalsescientpharma.com · Jul 2018Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Protein-Coupled Receptor (GPCR)-Targeted Drugs to Address Serious, Unserved Medical Needs - Escient pharmaceuticalsescientpharma.com · May 2018Escient Pharmaceuticals Launches with $40 Million - BioSpacebiospace.com · May 2018

Frequently asked questions

Who founded Thumbnail for Escient Pharmaceuticals?
Thumbnail for Escient Pharmaceuticals was founded by Alain Baron in 2017.
Who are Thumbnail for Escient Pharmaceuticals's investors?
Thumbnail for Escient Pharmaceuticals's investors include 5AM Ventures, Avego BioScience Capital, New Enterprise Associates (NEA), OUP (Osage University Partners), Sanofi Ventures, The Column Group, Abingworth, ALTITUDE LIFE SCIENCE VENTURES and 2 more.
How much funding has Thumbnail for Escient Pharmaceuticals raised?
Thumbnail for Escient Pharmaceuticals has disclosed $108.8M raised across 3 rounds.
Where is Thumbnail for Escient Pharmaceuticals headquartered?
Thumbnail for Escient Pharmaceuticals is headquartered in San Diego, US.